Online Media Kit


March 06, 2018 | POZ

Vaginal Ring Appears to Cut Women's HIV Rate in Half in New Study

The open-label follow-up to a previous placebo-controlled study of an HIV-preventing ring is seeing high use among women. More »


December 19, 2017 | BBC World Hacks

The Ring That Could Help Save Women's Lives (AUDIO)

A new form of protection being tested in Malawi could be a real game-changer. World Hacks meets the women pioneering this approach and taking control of their own protection. More »


May 04, 2017 | Economist (UK)

How to protect women against both HIV and pregnancy

A newly-developed vaginal ring releases small doses of drugs over a three-month period More »


February 26, 2016 | The New York Times editorial

Helping Women in Africa Avoid H.I.V.

Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »

Media Highlights

February 12, 2019 | ContagionLIVE

REACH Study to Evaluate PrEP and Vaginal Ring for HIV Prevention

The trial is designed to examine the safety of oral PrEP and a vaginal ring option in adolescent girls and young women in southern Africa.  More »

January 01, 2019 | Positively Aware

Emerging Options

Doctors and advocates discuss treatment and prevention breakthroughs on the horizon More »

December 31, 2018 | Specialty Medical Dialogues (India)

Dapivirine use for HIV prevention safe in periconception period

The study, published in the Journal of Acquired Immune Deficiency Syndromes, shows that dapivirine use in the periconception period does not seem to be associated with adverse effects on pregnancy or... More »

November 29, 2018 | Johnson & Johnson News

"I Have HIV": This Researcher Is Fighting the Disease—and the Stigma Attached to It

Johnson & Johnson profiles IPM Scientific Advisory Board member Jens Van Roey. More »

November 01, 2018 | The Body PRO

Dapivirine Vaginal Ring for PrEP Does Not Lead to Drug Resistance

MTN research presented at R4P 2018 found that use of the dapivirine vaginal ring did not lead to resistance mutations in women participating in ASPIRE who seroconverted.  More »